ESMO 2018 | Immuno-oncology in renal cell carcinoma: new combinations are coming

Hans Hammers

Hans Hammers, MD, PhD, of the University of Texas Southwestern Medical Center, Texas, USA, discusses the immunotherapeutic landscape for renal cell carcinoma, including upcoming combinations. This interview took place at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.

Share this video